Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04964674 · ClinicalTrials.gov registry record · NA

Psychometric Testing and Cue Utilization During Cued Visual Search

A NA study, sponsored by Lehigh University.

Terminated
Registry status
NA
Development phase
122
Enrollment target

NCT04964674: Clinical Trial NA study, sponsored by Lehigh University.

NCT04964674 is a NA study that was terminated before completion, run by Lehigh University. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04964674, a NA study, was terminated before completion, sponsored by Lehigh University.

TERMINATED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

The experimenters will examine the relationship between utilization of positive (target cue) and negative (distractor cue) templates during a cued visual search task with performance on a set of measures related to executive functions associated with attentional control: shifting, updating, and inhibition.

Primary Outcome

Reaction times on visual search task with positive, negative, and neutral cues

Interventions

  • BEHAVIORAL Behavioral Measurement

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2021-04-12
Est. Completion 2022-08-27
Phase NA
Lehigh University

12 total trials

Why NCT04964674 stopped before completion

NCT04964674 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral Measurement is the first listed.

NCT04964674 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04964674 about?

NCT04964674 is a clinical study titled "Psychometric Testing and Cue Utilization During Cued Visual Search". The experimenters will examine the relationship between utilization of positive (target cue) and negative (distractor cue) templates during a cued visual search task with performance on a set of measures related to executive functions associated with attentional control: shifting, updating, and inhi...

What is the current status of trial NCT04964674?

This trial is currently terminated. It is a NA study. The enrollment target is 122 participants. The study started on 2021-04-12. Estimated completion is 2022-08-27.

What interventions are being tested in trial NCT04964674?

The interventions under investigation include: Behavioral Measurement (BEHAVIORAL).

Who is sponsoring clinical trial NCT04964674?

This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04964674's enrollment target sits among peer trials

122 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04964674, the US trial registry maintained by the National Library of Medicine. NCT04964674 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.